TIGIT blockade enhances cytolytic function in antigen-specific CTLs in a manner non-redundant to PD1 blockade

被引：0
|
作者：
Malhotra, Deepali [1 ]
Moody, Gordon [1 ]
Overstreet, Michael [1 ]
Mumm, John [1 ]
机构：
[1] MedImmune, Gaithersburg, MD USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-4720
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4720
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs
    Wong, Raymond M.
    Scotland, Ron R.
    Lau, Roy L.
    Wang, Changyu
    Korman, Alan J.
    Kast, W. M.
    Weber, Jeffrey S.
    INTERNATIONAL IMMUNOLOGY, 2007, 19 (10) : 1223 - 1234
  • [2] ALL Progression Induces PD1 on T Cells and Blockade of PD1 Enhances Adoptive Immunotherapy
    Burk, Chad R.
    Fix, William
    Qin, Haiying
    Fry, Terry J.
    BLOOD, 2011, 118 (21) : 1110 - 1111
  • [3] PVRL1/TIGIT pathway is responsible for PD1 blockade resistance in liver cancer
    Chiu, D. K-C.
    Ng, I. O-L.
    Wong, C. C-L.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1731 - 1731
  • [4] Bezafibrate enhances PD-1 blockade efficacy by activating mitochondrial biogenesis and effector function of CTLs
    Kumar, Alok
    Chowdhury, Partha S.
    Chamoto, Kenji
    Honjo, Tasuku
    CANCER SCIENCE, 2018, 109 : 624 - 624
  • [5] PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+CD25Hi regulatory T cells
    Wang, Wenshi
    Lau, Roy
    Yu, Daohai
    Zhu, Weiwei
    Korman, Alan
    Weber, Jeffrey
    INTERNATIONAL IMMUNOLOGY, 2009, 21 (09) : 1065 - 1077
  • [6] TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM
    Hung, Alice L.
    Maxwell, Russell
    Theodros, Debebe
    Belcaid, Zineb
    Mathios, Dimitrios
    Luksik, Andrew S.
    Kim, Eileen
    Wu, Adela
    Xia, Yuanxuan
    Garzon-Muvdi, Tomas
    Jackson, Christopher
    Ye, Xiaobu
    Tyler, Betty
    Selby, Mark
    Korman, Alan
    Barnhart, Bryan
    Park, Su-Myeong
    Youn, Je-In
    Chowdhury, Tamrin
    Park, Chul-Kee
    Brem, Henry
    Pardoll, Drew M.
    Lim, Michael
    ONCOIMMUNOLOGY, 2018, 7 (08):
  • [7] Indoximod Strongly Enhances Effects of Combined Hrt and PD1/PD-L1 Checkpoint Blockade
    Watanabe, T.
    Niedermann, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E652 - E652
  • [8] Combination GITR targeting/PD-1 blockade with vaccination drives robust antigen-specific antitumor immunity
    Villarreal, Daniel O.
    Chin, Diana
    Smith, Melissa A.
    Luistro, Leopoldo L.
    Snyder, Linda A.
    ONCOTARGET, 2017, 8 (24) : 39117 - 39130
  • [9] Combination TIGIT/PD-1 blockade enhances the efficacy of neoantigen vaccines in a model of pancreatic cancer
    Peng, Hui
    Li, Lijin
    Zuo, Chong
    Chen, Michael Y.
    Zhang, Xiuli
    Myers, Nancy B.
    Hogg, Graham D.
    DeNardo, David G.
    Goedegebuure, S. Peter
    Hawkins, William G.
    Gillanders, William E.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [10] IDO inhibition strongly enhances effects of combined hRT and PD1/PD-L1 checkpoint blockade
    Watanabe, T.
    Niedermann, G.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S72 - S73
12345